About Us
The MCED Consortium is an independent, nonprofit, US/UK public-private consortium. Directed by our mission statement and guiding principles, the consortium aims to evaluate emerging data from MCED studies and establish standards in MCED technology by defining the clinical and public-health value of the technology, providing guidance for its use in clinical practice, and developing a public-outreach approach that identifies and mitigates potential health inequities that could arise from the use of MCED technology.
-
To reduce the burden of cancer by evaluating how MCED technologies may improve cancer detection, treatment, and care to benefit all people.
-
To evaluate and assess the benefits and risks, potential outcomes, costs, and value associated with introducing novel MCED technologies into society and clinical care;
To develop guidance for the potential introduction of these technologies into clinical care, including understanding public perceptions of MCED technologies and these technologies’ potential to improve or exacerbate health disparities;
To accelerate additional lessons and evaluations on how MCED technologies could potentially improve outcomes for all people.